2012-06-01
AUTHORS ABSTRACTSignificant renal artery stenosis (RAS) may result in deterioration of arterial hypertension and/or renal insufficiency and may contribute to cardiovascular diseases such as diastolic and systolic heart failure. Balloon angioplasty (PTA) is the established therapy for RAS of fibromuscular disease (FMD) and inflammation origin; the role of cutting balloon angioplasty in this indication needs still to be investigated. In atherosclerotic RAS, stenting has shown superior acute and long-term technical outcomes compared to PTA. Technical improvements such as dedicated guiding catheters and the downsizing of devices including wires, balloon catheters and stents made the intervention more successful and safer. Numerous single-centre studies have reported the beneficial effect of percutaneous revascularisation of RAS of different aetiologies. Even if the recently published randomised STAR and ASTRAL trials did not show any benefit of renal artery stenosis revascularisation over medical therapy in selected patient cohorts, there is nonetheless evidence that stenting of haemodynamically relevant atherosclerotic RAS has an impact on blood pressure control, renal function, left ventricular hypertrophy and even patient survival. This chapter introduces the interventional treatment techniques including management of complications and peri-procedural care step by step.Renal artery revascularisation is a feasible and safe procedure in experienced hands provided dedicated equipment is available. However, there remain particular risks such as a ‘hostile aorta’ with a high soft plaque burden and difficult anatomical conditions that can result in a disastrous interventional outcome. Key for a beneficial interventional outcome is an appropriate interventional plan, the appropriate equipment and, most important, the correct patient selection. Having this in mind, renal revascularisation is still indicated in a well-defined subset of patients with obstructive renal artery disease. More... »
PAGES907-923
Catheter-Based Cardiovascular Interventions
ISBN
978-3-642-27675-0
978-3-642-27676-7
http://scigraph.springernature.com/pub.10.1007/978-3-642-27676-7_56
DOIhttp://dx.doi.org/10.1007/978-3-642-27676-7_56
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1014305320
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Cardiorespiratory Medicine and Haematology",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Abteilung Angiologie, Heart Centre Bad Krozingen, Bad Krozingen, Germany",
"id": "http://www.grid.ac/institutes/grid.418466.9",
"name": [
"Abteilung Angiologie, Heart Centre Bad Krozingen, Bad Krozingen, Germany"
],
"type": "Organization"
},
"familyName": "Zeller",
"givenName": "Thomas",
"id": "sg:person.01306206724.74",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306206724.74"
],
"type": "Person"
}
],
"datePublished": "2012-06-01",
"datePublishedReg": "2012-06-01",
"description": "Significant renal artery stenosis (RAS) may result in deterioration of arterial hypertension and/or renal insufficiency and may contribute to cardiovascular diseases such as diastolic and systolic heart failure. Balloon angioplasty (PTA) is the established therapy for RAS of fibromuscular disease (FMD) and inflammation origin; the role of cutting balloon angioplasty in this indication needs still to be investigated. In atherosclerotic RAS, stenting has shown superior acute and long-term technical outcomes compared to PTA. Technical improvements such as dedicated guiding catheters and the downsizing of devices including wires, balloon catheters and stents made the intervention more successful and safer. Numerous single-centre studies have reported the beneficial effect of percutaneous revascularisation of RAS of different aetiologies. Even if the recently published randomised STAR and ASTRAL trials did not show any benefit of renal artery stenosis revascularisation over medical therapy in selected patient cohorts, there is nonetheless evidence that stenting of haemodynamically relevant atherosclerotic RAS has an impact on blood pressure control, renal function, left ventricular hypertrophy and even patient survival. This chapter introduces the interventional treatment techniques including management of complications and peri-procedural care step by step.Renal artery revascularisation is a feasible and safe procedure in experienced hands provided dedicated equipment is available. However, there remain particular risks such as a \u2018hostile aorta\u2019 with a high soft plaque burden and difficult anatomical conditions that can result in a disastrous interventional outcome. Key for a beneficial interventional outcome is an appropriate interventional plan, the appropriate equipment and, most important, the correct patient selection. Having this in mind, renal revascularisation is still indicated in a well-defined subset of patients with obstructive renal artery disease.",
"editor": [
{
"familyName": "Lanzer",
"givenName": "Peter",
"type": "Person"
}
],
"genre": "chapter",
"id": "sg:pub.10.1007/978-3-642-27676-7_56",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": {
"isbn": [
"978-3-642-27675-0",
"978-3-642-27676-7"
],
"name": "Catheter-Based Cardiovascular Interventions",
"type": "Book"
},
"keywords": [
"renal artery stenosis",
"atherosclerotic renal artery stenosis",
"fibromuscular disease",
"balloon angioplasty",
"interventional outcomes",
"relevant atherosclerotic renal artery stenosis",
"numerous single-center studies",
"obstructive renal artery disease",
"significant renal artery stenosis",
"interventional treatment techniques",
"renal artery revascularisation",
"systolic heart failure",
"blood pressure control",
"single-center study",
"subset of patients",
"renal artery disease",
"correct patient selection",
"management of complications",
"difficult anatomical conditions",
"ASTRAL trial",
"care steps",
"renal revascularisation",
"arterial hypertension",
"renal insufficiency",
"renal function",
"heart failure",
"artery disease",
"percutaneous revascularisation",
"medical therapy",
"ventricular hypertrophy",
"endovascular treatment",
"artery stenosis",
"patient survival",
"plaque burden",
"patient selection",
"renal artery",
"patient cohort",
"safe procedure",
"experienced hands",
"balloon catheter",
"different etiologies",
"cardiovascular disease",
"interventional plan",
"revascularisation",
"anatomical conditions",
"pressure control",
"beneficial effects",
"particular risk",
"technical outcomes",
"disease",
"angioplasty",
"catheter",
"therapy",
"outcomes",
"appropriate equipment",
"treatment techniques",
"hypertension",
"stenting",
"stenosis",
"complications",
"patients",
"artery",
"hypertrophy",
"aorta",
"insufficiency",
"etiology",
"cohort",
"technical improvements",
"stents",
"trials",
"survival",
"intervention",
"treatment",
"burden",
"risk",
"indications",
"dedicated equipment",
"failure",
"PTA",
"subset",
"deterioration",
"evidence",
"management",
"control",
"study",
"role",
"benefits",
"effect",
"procedure",
"improvement",
"function",
"plan",
"impact",
"hand",
"origin",
"conditions",
"technique",
"equipment",
"selection",
"step",
"mind",
"chapter",
"devices",
"wire",
"downsizing",
"stars"
],
"name": "Endovascular Treatment of Renal Arteries",
"pagination": "907-923",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1014305320"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/978-3-642-27676-7_56"
]
}
],
"publisher": {
"name": "Springer Nature",
"type": "Organisation"
},
"sameAs": [
"https://doi.org/10.1007/978-3-642-27676-7_56",
"https://app.dimensions.ai/details/publication/pub.1014305320"
],
"sdDataset": "chapters",
"sdDatePublished": "2022-05-10T10:44",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/chapter/chapter_263.jsonl",
"type": "Chapter",
"url": "https://doi.org/10.1007/978-3-642-27676-7_56"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-27676-7_56'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-27676-7_56'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-27676-7_56'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-27676-7_56'
This table displays all metadata directly associated to this object as RDF triples.
166 TRIPLES
23 PREDICATES
130 URIs
123 LITERALS
7 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/978-3-642-27676-7_56 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1102 |
3 | ″ | schema:author | Ndbfc0647ebd046ef8cba4012c0f71a68 |
4 | ″ | schema:datePublished | 2012-06-01 |
5 | ″ | schema:datePublishedReg | 2012-06-01 |
6 | ″ | schema:description | Significant renal artery stenosis (RAS) may result in deterioration of arterial hypertension and/or renal insufficiency and may contribute to cardiovascular diseases such as diastolic and systolic heart failure. Balloon angioplasty (PTA) is the established therapy for RAS of fibromuscular disease (FMD) and inflammation origin; the role of cutting balloon angioplasty in this indication needs still to be investigated. In atherosclerotic RAS, stenting has shown superior acute and long-term technical outcomes compared to PTA. Technical improvements such as dedicated guiding catheters and the downsizing of devices including wires, balloon catheters and stents made the intervention more successful and safer. Numerous single-centre studies have reported the beneficial effect of percutaneous revascularisation of RAS of different aetiologies. Even if the recently published randomised STAR and ASTRAL trials did not show any benefit of renal artery stenosis revascularisation over medical therapy in selected patient cohorts, there is nonetheless evidence that stenting of haemodynamically relevant atherosclerotic RAS has an impact on blood pressure control, renal function, left ventricular hypertrophy and even patient survival. This chapter introduces the interventional treatment techniques including management of complications and peri-procedural care step by step.Renal artery revascularisation is a feasible and safe procedure in experienced hands provided dedicated equipment is available. However, there remain particular risks such as a ‘hostile aorta’ with a high soft plaque burden and difficult anatomical conditions that can result in a disastrous interventional outcome. Key for a beneficial interventional outcome is an appropriate interventional plan, the appropriate equipment and, most important, the correct patient selection. Having this in mind, renal revascularisation is still indicated in a well-defined subset of patients with obstructive renal artery disease. |
7 | ″ | schema:editor | Nb0468812db9c4e9daabf0e46e9cc6549 |
8 | ″ | schema:genre | chapter |
9 | ″ | schema:inLanguage | en |
10 | ″ | schema:isAccessibleForFree | false |
11 | ″ | schema:isPartOf | N1e25dc065aeb4da7bb3b409f14a0f037 |
12 | ″ | schema:keywords | ASTRAL trial |
13 | ″ | ″ | PTA |
14 | ″ | ″ | anatomical conditions |
15 | ″ | ″ | angioplasty |
16 | ″ | ″ | aorta |
17 | ″ | ″ | appropriate equipment |
18 | ″ | ″ | arterial hypertension |
19 | ″ | ″ | artery |
20 | ″ | ″ | artery disease |
21 | ″ | ″ | artery stenosis |
22 | ″ | ″ | atherosclerotic renal artery stenosis |
23 | ″ | ″ | balloon angioplasty |
24 | ″ | ″ | balloon catheter |
25 | ″ | ″ | beneficial effects |
26 | ″ | ″ | benefits |
27 | ″ | ″ | blood pressure control |
28 | ″ | ″ | burden |
29 | ″ | ″ | cardiovascular disease |
30 | ″ | ″ | care steps |
31 | ″ | ″ | catheter |
32 | ″ | ″ | chapter |
33 | ″ | ″ | cohort |
34 | ″ | ″ | complications |
35 | ″ | ″ | conditions |
36 | ″ | ″ | control |
37 | ″ | ″ | correct patient selection |
38 | ″ | ″ | dedicated equipment |
39 | ″ | ″ | deterioration |
40 | ″ | ″ | devices |
41 | ″ | ″ | different etiologies |
42 | ″ | ″ | difficult anatomical conditions |
43 | ″ | ″ | disease |
44 | ″ | ″ | downsizing |
45 | ″ | ″ | effect |
46 | ″ | ″ | endovascular treatment |
47 | ″ | ″ | equipment |
48 | ″ | ″ | etiology |
49 | ″ | ″ | evidence |
50 | ″ | ″ | experienced hands |
51 | ″ | ″ | failure |
52 | ″ | ″ | fibromuscular disease |
53 | ″ | ″ | function |
54 | ″ | ″ | hand |
55 | ″ | ″ | heart failure |
56 | ″ | ″ | hypertension |
57 | ″ | ″ | hypertrophy |
58 | ″ | ″ | impact |
59 | ″ | ″ | improvement |
60 | ″ | ″ | indications |
61 | ″ | ″ | insufficiency |
62 | ″ | ″ | intervention |
63 | ″ | ″ | interventional outcomes |
64 | ″ | ″ | interventional plan |
65 | ″ | ″ | interventional treatment techniques |
66 | ″ | ″ | management |
67 | ″ | ″ | management of complications |
68 | ″ | ″ | medical therapy |
69 | ″ | ″ | mind |
70 | ″ | ″ | numerous single-center studies |
71 | ″ | ″ | obstructive renal artery disease |
72 | ″ | ″ | origin |
73 | ″ | ″ | outcomes |
74 | ″ | ″ | particular risk |
75 | ″ | ″ | patient cohort |
76 | ″ | ″ | patient selection |
77 | ″ | ″ | patient survival |
78 | ″ | ″ | patients |
79 | ″ | ″ | percutaneous revascularisation |
80 | ″ | ″ | plan |
81 | ″ | ″ | plaque burden |
82 | ″ | ″ | pressure control |
83 | ″ | ″ | procedure |
84 | ″ | ″ | relevant atherosclerotic renal artery stenosis |
85 | ″ | ″ | renal artery |
86 | ″ | ″ | renal artery disease |
87 | ″ | ″ | renal artery revascularisation |
88 | ″ | ″ | renal artery stenosis |
89 | ″ | ″ | renal function |
90 | ″ | ″ | renal insufficiency |
91 | ″ | ″ | renal revascularisation |
92 | ″ | ″ | revascularisation |
93 | ″ | ″ | risk |
94 | ″ | ″ | role |
95 | ″ | ″ | safe procedure |
96 | ″ | ″ | selection |
97 | ″ | ″ | significant renal artery stenosis |
98 | ″ | ″ | single-center study |
99 | ″ | ″ | stars |
100 | ″ | ″ | stenosis |
101 | ″ | ″ | stenting |
102 | ″ | ″ | stents |
103 | ″ | ″ | step |
104 | ″ | ″ | study |
105 | ″ | ″ | subset |
106 | ″ | ″ | subset of patients |
107 | ″ | ″ | survival |
108 | ″ | ″ | systolic heart failure |
109 | ″ | ″ | technical improvements |
110 | ″ | ″ | technical outcomes |
111 | ″ | ″ | technique |
112 | ″ | ″ | therapy |
113 | ″ | ″ | treatment |
114 | ″ | ″ | treatment techniques |
115 | ″ | ″ | trials |
116 | ″ | ″ | ventricular hypertrophy |
117 | ″ | ″ | wire |
118 | ″ | schema:name | Endovascular Treatment of Renal Arteries |
119 | ″ | schema:pagination | 907-923 |
120 | ″ | schema:productId | N24161a09698d46e2a549ae738c84fb89 |
121 | ″ | ″ | Nf26d08e919d14a8b83c5c5b8d8b16ccd |
122 | ″ | schema:publisher | N47feb8eda2b84d859900cb511e343b5a |
123 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1014305320 |
124 | ″ | ″ | https://doi.org/10.1007/978-3-642-27676-7_56 |
125 | ″ | schema:sdDatePublished | 2022-05-10T10:44 |
126 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
127 | ″ | schema:sdPublisher | Nb472864d1c70405d961b089a73fe7fc7 |
128 | ″ | schema:url | https://doi.org/10.1007/978-3-642-27676-7_56 |
129 | ″ | sgo:license | sg:explorer/license/ |
130 | ″ | sgo:sdDataset | chapters |
131 | ″ | rdf:type | schema:Chapter |
132 | N1e25dc065aeb4da7bb3b409f14a0f037 | schema:isbn | 978-3-642-27675-0 |
133 | ″ | ″ | 978-3-642-27676-7 |
134 | ″ | schema:name | Catheter-Based Cardiovascular Interventions |
135 | ″ | rdf:type | schema:Book |
136 | N24161a09698d46e2a549ae738c84fb89 | schema:name | doi |
137 | ″ | schema:value | 10.1007/978-3-642-27676-7_56 |
138 | ″ | rdf:type | schema:PropertyValue |
139 | N47feb8eda2b84d859900cb511e343b5a | schema:name | Springer Nature |
140 | ″ | rdf:type | schema:Organisation |
141 | Nb0468812db9c4e9daabf0e46e9cc6549 | rdf:first | Nb7824e1d44f04db7842c6c2256cd6ffd |
142 | ″ | rdf:rest | rdf:nil |
143 | Nb472864d1c70405d961b089a73fe7fc7 | schema:name | Springer Nature - SN SciGraph project |
144 | ″ | rdf:type | schema:Organization |
145 | Nb7824e1d44f04db7842c6c2256cd6ffd | schema:familyName | Lanzer |
146 | ″ | schema:givenName | Peter |
147 | ″ | rdf:type | schema:Person |
148 | Ndbfc0647ebd046ef8cba4012c0f71a68 | rdf:first | sg:person.01306206724.74 |
149 | ″ | rdf:rest | rdf:nil |
150 | Nf26d08e919d14a8b83c5c5b8d8b16ccd | schema:name | dimensions_id |
151 | ″ | schema:value | pub.1014305320 |
152 | ″ | rdf:type | schema:PropertyValue |
153 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
154 | ″ | schema:name | Medical and Health Sciences |
155 | ″ | rdf:type | schema:DefinedTerm |
156 | anzsrc-for:1102 | schema:inDefinedTermSet | anzsrc-for: |
157 | ″ | schema:name | Cardiorespiratory Medicine and Haematology |
158 | ″ | rdf:type | schema:DefinedTerm |
159 | sg:person.01306206724.74 | schema:affiliation | grid-institutes:grid.418466.9 |
160 | ″ | schema:familyName | Zeller |
161 | ″ | schema:givenName | Thomas |
162 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306206724.74 |
163 | ″ | rdf:type | schema:Person |
164 | grid-institutes:grid.418466.9 | schema:alternateName | Abteilung Angiologie, Heart Centre Bad Krozingen, Bad Krozingen, Germany |
165 | ″ | schema:name | Abteilung Angiologie, Heart Centre Bad Krozingen, Bad Krozingen, Germany |
166 | ″ | rdf:type | schema:Organization |